Description
Founded in 2016, Medicxi is a venture capital firm based in London, United Kingdom. The firm prefers to invest in the healthcare, biotechnology, and pharmaceutical sectors.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
NewAmsterdam Pharma | 15-Nov-2022 | PIPE | 00000 | Drug Discovery | Clinical Trials - Phase 3 | |
00000000 000000000 | 01-Nov-2022 | 00000 00000 | Drug Discovery | Generating Revenue | 000000000 00000000 00.0 | |
0000000 | 01-Nov-2022 | 00000 00000 | Drug Discovery | Startup | 000000000 00 00000000 00.0 | |
00000 000000000000 | 22-Sep-2022 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 2 | 000000000 00000000 00.0 |
0000000 | 21-Jul-2022 | 0000 00000 | 0000 | Drug Discovery | Startup | |
0000000 | 29-Jun-2022 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 0000 00000000 00.0 |
00000000 000000000 | 31-Mar-2022 | 00000 00000 | 00.000 | Drug Discovery | Pre-Clinical Trials | 0000è00 000000 00 |
000000 00000000000 | 22-Dec-2021 | 00000 00000 | 0000 | Drug Discovery | Startup | 0000è00 000000 00 |
Xenikos | 02-Sep-2021 | Later Stage VC | 000.00 | Drug Discovery | Generating Revenue | 000000000 00 00000000 00.0 |
Perfect Balance | 01-Sep-2021 | Early Stage VC | Drug Discovery | Stealth | 00000000 000000 |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
MiroBio | 03-Aug-2022 | Merger/Acquisition | 00000 |
000000 0000000 | 10-Jan-2022 | 000 00 00000000 | |
0000 00000000000 | 02-Nov-2021 | 000 | 000.00 |
00000000 000000000 | 28-May-2021 | 000 | 00000 |
00000 | 01-May-2021 | 000000000 00000000 | |
000000000-00 | 23-Feb-2021 | 000000000000000000 | |
0000000 0000000000 | 16-Feb-2021 | 000000000000000000 | |
000000 | 16-Feb-2021 | 000000000000000000 | |
Orexia | 16-Feb-2021 | Merger/Acquisition | |
PearlRiver Bio | 16-Feb-2021 | Merger/Acquisition |
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Giovanni Pericolini | Co-Founding Partner | London, United Kingdom | |||
Thibaut De Smedt Ph.D | Venture Partner | London, United Kingdom | |||
Francesco De Rubertis Ph.D | Co-Founder & Partner | 00 | 0 | 00 | Geneva, Switzerland |
Michèle Ollier MD | Co-Founder & Partner | 00 | 0 | 0 | Geneva, Switzerland |
Giovanni Mariggi Ph.D | Partner | 0 | 0 | 0 | London, United Kingdom |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
RA Capital Management | 5 | 0 |
![]() |
![]() |
|
Longitude Capital | 0 | 0 |
![]() |
![]() |
|
Roche Venture Fund | 0 | 0 | 0 |
![]() |
![]() |
Advent Life Sciences | 0 | 0 | 0 |
![]() |
![]() |
Janus Henderson Investors | 0 | 0 |
![]() |
![]() |